{"id":"https://openalex.org/W6991979003","doi":null,"title":"Int\u00e9r\u00eat des param\u00e8tres m\u00e9taboliques de la TEP-TDM au 18F-FDG dans l\u2019\u00e9valuation des patients trait\u00e9s par immunoth\u00e9rapie pour un cancer broncho-pulmonaire non \u00e0 petites cellules","display_name":"Int\u00e9r\u00eat des param\u00e8tres m\u00e9taboliques de la TEP-TDM au 18F-FDG dans l\u2019\u00e9valuation des patients trait\u00e9s par immunoth\u00e9rapie pour un cancer broncho-pulmonaire non \u00e0 petites cellules","alternate_titles":[],"publication_year":2022,"publication_date":"2022-10-21","ids":{"openalex":"https://openalex.org/W6991979003"},"language":"en","primary_location":{"id":"pmh:oai:HAL:dumas-03884820v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/dumas-03884820v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"M\u00e9decine humaine et pathologie. 2022","raw_type":"info:eu-repo/semantics/masterThesis"},"parent_works":[],"lineage":["https://openalex.org/W6991979003"],"child_works_count":0,"type":"dissertation","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://hal.science/dumas-03884820v1","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089349083","display_name":"Pierre Tricarico","orcid":"https://orcid.org/0009-0008-0761-6795","observed_orcids":["https://orcid.org/0009-0008-0761-6795"]},"institutions":[{"id":"https://openalex.org/I201841394","display_name":"Universit\u00e9 C\u00f4te d'Azur","ror":"https://ror.org/019tgvf94","country_code":"FR","type":"education","lineage":["https://openalex.org/I201841394"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Tricarico, Pierre","raw_affiliation_strings":["UCA Facult\u00e9 M\u00e9decine - Universit\u00e9 C\u00f4te d'Azur - Facult\u00e9 de M\u00e9decine (28, Avenue de Valombrose - 06107 Nice Cedex 2 - France)"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCA Facult\u00e9 M\u00e9decine - Universit\u00e9 C\u00f4te d'Azur - Facult\u00e9 de M\u00e9decine (28, Avenue de Valombrose - 06107 Nice Cedex 2 - France)","institution_ids":["https://openalex.org/I201841394"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5089349083"],"corresponding_institution_ids":["https://openalex.org/I201841394"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.5454000234603882,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.5454000234603882,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.35989999771118164,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12422","display_name":"Radiomics and Machine Learning in Medical Imaging","score":0.02879999950528145,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9620000123977661},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.8040000200271606},{"id":"https://openalex.org/keywords/18f-fdg-pet-ct","display_name":"18F-FDG PET/CT","score":0.921999990940094},{"id":"https://openalex.org/keywords/metabolic-tumor-volume","display_name":"metabolic tumor volume","score":0.9419999718666077},{"id":"https://openalex.org/keywords/total-lesion-glycolysis","display_name":"total lesion glycolysis","score":0.9089999794960022},{"id":"https://openalex.org/keywords/suvmax","display_name":"SUVmax","score":0.8080000281333923},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7749999761581421},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8709999918937683},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7639999985694885},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":1.0},{"id":"https://openalex.org/keywords/patient-stratification","display_name":"patient stratification","score":0.7360000014305115},{"id":"https://openalex.org/keywords/predictive-thresholds","display_name":"predictive thresholds","score":0.31200000643730164},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.5649999976158142},{"id":"https://openalex.org/keywords/pd-1-inhibitors","display_name":"PD-1 inhibitors","score":0.5479999780654907}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7549999952316284},{"id":"https://openalex.org/C3019719930","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value","level":2,"score":0.6414999961853027},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.5396000146865845},{"id":"https://openalex.org/C58471807","wikidata":"https://www.wikidata.org/wiki/Q327120","display_name":"Receiver operating characteristic","level":2,"score":0.4885999858379364},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4375},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.39089998602867126},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3763999938964844},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.36579999327659607},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.36399999260902405},{"id":"https://openalex.org/C198433322","wikidata":"https://www.wikidata.org/wiki/Q3910099","display_name":"Predictive value of tests","level":2,"score":0.36309999227523804},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.36079999804496765},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.35850000381469727},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.349700003862381},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.3294000029563904},{"id":"https://openalex.org/C199374082","wikidata":"https://www.wikidata.org/wiki/Q907080","display_name":"Standardized uptake value","level":3,"score":0.323199987411499},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.2703000009059906},{"id":"https://openalex.org/C509974204","wikidata":"https://www.wikidata.org/wiki/Q180507","display_name":"Radiation therapy","level":2,"score":0.2623000144958496},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.26179999113082886},{"id":"https://openalex.org/C2775842073","wikidata":"https://www.wikidata.org/wiki/Q208376","display_name":"Positron emission tomography","level":2,"score":0.2615000009536743}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:HAL:dumas-03884820v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/dumas-03884820v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"M\u00e9decine humaine et pathologie. 2022","raw_type":"info:eu-repo/semantics/masterThesis"}],"best_oa_location":{"id":"pmh:oai:HAL:dumas-03884820v1","doi":null,"is_oa":true,"landing_page_url":"https://hal.science/dumas-03884820v1","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"M\u00e9decine humaine et pathologie. 2022","raw_type":"info:eu-repo/semantics/masterThesis"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7062599747","https://openalex.org/W4395014773","https://openalex.org/W4404020467","https://openalex.org/W3044807957","https://openalex.org/W4385331508","https://openalex.org/W3121830331","https://openalex.org/W7204199528","https://openalex.org/W2980909879","https://openalex.org/W3173964467","https://openalex.org/W4309614801"],"abstract_inverted_index":{"The":[0,23,62,134],"management":[1],"of":[2,25,36,73,105,131,150,164,179,219,250,305,328],"patients":[3,52,231,251,293,314],"with":[4,12,121,295,318],"metastatic":[5,298],"non-small":[6],"cell":[7],"lung":[8],"cancer":[9],"(NSCLC)":[10],"treated":[11,294],"immunotherapy":[13,296],"requires":[14],"new":[15],"predictive":[16,32,135,163,178,202,290],"biomarkers":[17],"for":[18,46,128,137,144,175,204,252,297,324],"the":[19,31,71,156,171,187,193,326],"response":[20],"to":[21,29],"treatment.":[22],"aim":[24],"this":[26],"study":[27],"was":[28,111,153],"assess":[30],"and":[33,49,56,78,97,102,143,160,182,207,228,241,254,263,271],"prognostic":[34,303],"value":[35,87,136,203],"metabolic":[37,89,108,189,275],"parameters":[38,63,152,172],"measured":[39,65],"by":[40,113,222,229],"18-fluorodeoxyglucose":[41],"positron-emission":[42],"tomography":[43],"(18F-FDG":[44],"PET-CT)":[45],"these":[47,151],"patients.Material":[48],"methods:":[50],"123":[51],"were":[53,60,64,126],"prospectively":[54],"included":[55],"data":[57],"from":[58],"119":[59],"analyzed.":[61],"on":[66,155,192,280],"examinations":[67],"carried":[68],"out":[69],"before":[70],"start":[72],"immunotherapy,":[74],"after":[75,79],"6-8":[76],"weeks":[77],"12-16":[80],"weeks.":[81],"These":[82],"are":[83,162,177],"maximum":[84],"standardized":[85],"uptake":[86],"(SUVmax),":[88],"tumor":[90,107,190,276,322],"volume":[91,109,191,277],"(MTV),":[92],"total":[93,106],"lesion":[94],"glycolysis":[95],"(TLG),":[96],"their":[98],"variation,":[99],"\u0394SUVmax,":[100],"\u0394MTV":[101],"\u0394TLG.":[103],"Determination":[104],"(MTV)":[110],"performed":[112],"manual":[114],"segmentation,":[115],"using":[116,215],"an":[117,216,247,281,310],"absolute":[118],"fixed":[119],"threshold":[120,218],"SUV":[122],">":[123,243],"4.0.":[124],"Patients":[125],"followed":[127],"a":[129,200,288,319,336],"minimum":[130],"12":[132,141],"months.":[133],"overall":[138,165,180,205,253],"survival":[139,146,181,206,209,256],"at":[140,147],"months":[142,149,258],"progression-free":[145,183,208,255],"6":[148],"evaluated.Results:":[154],"pre-treatment":[157],"examination,":[158,196],"MTV":[159],"TLG":[161],"survival.":[166,184],"On":[167],"post-treatment":[168,195,283],"examinations,":[169],"all":[170],"measured,":[173],"except":[174],"\u0394TLG2,":[176],"More":[185],"particularly,":[186],"residual":[188,274,321],"first":[194],"called":[197],"MTV1,":[198],"has":[199],"strong":[201,289],"(AUC:":[210],"0.82;":[211],"CI:":[212],"0.736-0.899).":[213],"By":[214],"optimal":[217],"57cm3":[220,240],"determined":[221],"receiver":[223],"operating":[224],"characteristic":[225],"(ROC)":[226],"curve":[227],"classifying":[230],"into":[232],"three":[233],"groups":[234],"(MTV1":[235],"=":[236,260,268],"0cm3,":[237],"MTV1":[238,242],"\u2264":[239],"57cm3),":[244],"we":[245],"obtain":[246],"efficient":[248],"stratification":[249,304],"(6-":[257],"PFS":[259],"100%,":[261,269],"78.3%":[262],"21%":[264],"respectively;":[265],"24-months":[266],"OS":[267],"67.1%":[270],"15.9%":[272],"respectively).Conclusion:":[273],"(MTV1)":[278],"assessed":[279],"early":[282],"18F-FDG":[284],"PET-CT":[285],"examination":[286],"is":[287],"biomarker":[291],"in":[292,312,332],"NSCLC.":[299],"It":[300,307],"allows":[301],"excellent":[302],"patients.":[306],"could":[308],"have":[309],"interest":[311],"selecting":[313],"classified":[315],"as":[316],"progressing,":[317],"low":[320],"volume,":[323],"whom":[325],"continuation":[327],"treatment,":[329],"alone":[330],"or":[331],"combination,":[333],"would":[334],"bring":[335],"benefit.":[337]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W6991979003","counts_by_year":[],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2025-10-10T00:00:00"}
